Companies
Watson-Marlow
a world leader in niche positive-displacement pump technology, with fieldbus (PROFINET) integration case studies specifically addressing upstream bioprocess feed pumping and the need to keep pump technology consistent between R&D and commercial-scale production to avoid slowing process validation.
- Country
- United Kingdom
Commercial
Coverage
| CN | EU | US | |
|---|---|---|---|
| analytics-pat | ✓ | ✓ | ✓ |
Regulatorsfdaemanmpa
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Revenue | £408.2 million (Full Year 2025) | spiraxgroup.com |
| Certification | ISO 9001:2008, ISO 11137, USP Class VI | wmfts.com |
| Regulatory approval | FDA, EMA, CFDA compliance support | wmfts.com |
| Production site | Falmouth (UK), Devens (USA), Yorkshire (UK), Portsmouth (UK) | wmfts.com |
| Capacity | Expansion of cleanrooms and tube extrusion lines; investment in new 11,000m2 facility in Portsmouth | wmfts.com |
Independent sources: spiraxgroup.com · wmfts.com
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Automated feed systems for bioreactors | analytics-pat | Low | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.